#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Heritable pulmonary arterial hypertension Glycogen storage disease type I Plasma cell myeloma refractory Palmoplantar pustulosis Hereditary hypophosphataemic rickets Human papilloma virus immunisation Malignant fibrous histiocytoma Progressive familial intrahepatic cholestasis Gastrointestinal neuroendocrine tumour Penile squamous cell carcinoma Lymphangioma Fragile X syndrome Germ cell cancer Kawasaki's disease Marginal zone lymphoma recurrent More trials…

    Learn about Rare Diseases

    Soft tissue sarcoma – Diagnostics Ocular melanoma – Treatment Hypereosinophilic syndrome – Trials in Disease Progressive multifocal leukoencephalopathy – Treatment Netherton’s syndrome – Trials in Disease Progressive supranuclear palsy – Life with Disease Leiomyosarcoma metastatic – Life with Disease Mast cell activation syndrome Inclusion body myositis – Treatment Malignant fibrous histiocytoma – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Vibozilimod Lysine Hydrochloride Ursodeoxycholic Acid Deferiprone Resmetirom Tiotropium Bromide Monohydrate Corifollitropin Alfa Anv600 CEFTAROLINE FOSAMIL Mr0005 Pilocarpine Nitrate Hypothalamic Phospholipids Ads-013 Ifezuntirgene Inilparvovec Azd8630 Levocabastine Hydrochloride Bleomycin Sulfate Ph. Eur. Ribociclib Duloxetine Macitentan More therapies…

    Learn about Your Condition

    Graft infection Short-bowel syndrome Compulsive sexual behaviour Neoplasm malignant Deep vein thrombosis Lysosomal storage disorder B-cell type acute leukaemia Double hit lymphoma Ischaemic skin ulcer Bladder cancer Hypertension Normal pressure hydrocephalus Exfoliation glaucoma Ligament operation Pterygium More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study Comparing Clofarabine/Busulfan and Fludarabine/Busulfan for Adults with Acute Myeloid Leukemia Eligible for Stem Cell Transplantation

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Clofarabine
    • Fludrocortisone Acetate
    • Ciclosporin
    France

  • Study on the Effectiveness of Pembrolizumab with Chemotherapy in Advanced Non-Small Cell Lung Cancer Patients with High PD-L1 Levels

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer stage IV
    Investigated Drugs:
    • Carboplatin
    • Cisplatin
    • Paclitaxel
    Italy

  • Study on Lithium Sulphate to Prevent Cognitive Impairment in Children After Brain Tumor Radiotherapy

    Recruiting

    2 1 1
    Investigated Diseases:
    • Brain neoplasm
    Investigated Drugs:
    • Lithium Sulphate, Anhydrous
    Denmark Sweden

  • Study on Infliximab and Corticosteroids for Treating Severe Colitis Caused by Immune Checkpoint Inhibitors in Patients

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Colitis
    Investigated Drugs:
    • Prednisolone
    • Infliximab
    • Methylprednisolone
    Denmark

  • Study on Durvalumab for Patients with High-Risk Endometrial Cancer After Surgery

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Endometrial cancer
    Investigated Drugs:
    • Durvalumab
    Belgium Czechia France Germany Italy The Netherlands

  • Study of Venetoclax and Decitabine for Patients with Relapsed or Refractory Acute Myeloid Leukemia (AML)

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Acute myeloid leukaemia
    Investigated Drugs:
    • Decitabine
    • Venetoclax
    Germany
Previous Page
1 … 584 585 586 587 588 … 1,654
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!